TET2 and atherosclerosis: Proteomic profiling of atherosclerotic plaques from TET2 CHIP carriers in the MISSION Biobank revealed enrichment of pathways related to lipid metabolism and inflammation, suggesting a mechanistic link between epigenetic dysregulation and accelerated atherosclerosis.